Results 11 to 20 of about 420,278 (145)

Caracterización de Neisseria gonorrhoeae mediante esquema NG-MAST y FTIR [PDF]

open access: yes
[EN] Sexually transmitted infections (STIs) represent a serious emerging public health problem affecting sexual and reproductive health worldwide. Gonococcal infection, caused by Neisseria gonorrhoeae, is the second most common bacterial STI after Chlamydia trachomatis. In recent years, its incidence has increased significantly in our country, with the
Valle Suárez, Lucía
core   +3 more sources

Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018

open access: yesAntimicrobial Agents and Chemotherapy, 2022
Azithromycin-resistant (AZIR) gonorrhea has been steadily increasing in Canada over the past decade, which is cause for alarm, as azithromycin (AZI) has been part of the combination therapy recommended by the Canadian Guidelines on Sexually Transmitted Infections (CGSTI) since 2012.
Pam Sawatzky   +10 more
openaire   +2 more sources

Genetic diversity of Neisseria gonorrhoeae multi-antigen sequence types in Russia and Europe

open access: yesInternational Journal of Infectious Diseases, 2020
Objectives: The goal of this work was to assess the genetic diversity of Neisseria gonorrhoeae isolates in Russia and Europe and to compare the distribution of the N.
Boris Shaskolskiy   +6 more
doaj   +1 more source

Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010–2013 [PDF]

open access: yesBMC Infectious Diseases, 2015
Gonorrhoea and widely spread antimicrobial resistance (AMR) in its etiological agent Neisseria gonorrhoeae are major public health concerns worldwide. Gonococcal AMR surveillance nationally and internationally, to identify emerging resistance and inform treatment guidelines, is imperative for public health purposes.
Lebedzeu, Fiodar   +9 more
openaire   +2 more sources

Mast cell activation syndrome: A new outlook

open access: yesМедицинская иммунология, 2023
Mast Cell Activation Syndrome (MCAS) is a severe relapsing disease requiring inpatient treatment, with clinical pattern including the features of anaphylaxis.
N. V. Mikryukova, N. M. Kalinina
doaj   +1 more source

Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders

open access: yesDiagnostics, 2023
Tryptase has proven to be a very useful and specific marker to demonstrate mast cell activation and degranulation when an acute (i.e., within 4 h after the event) and baseline value (i.e., at least 24 h after the event) are compared and meet the ...
Michiel Beyens   +4 more
doaj   +1 more source

Tanshinone IIA alleviates ovalbumin-induced allergic rhinitis symptoms by inhibiting Th2 cytokine production and mast cell histamine release in mice

open access: yesPharmaceutical Biology, 2022
Context Studies have shown that tanshinone IIA (TIIA) has an anti-inflammatory effect, but the effect on allergic rhinitis (AR) is unclear. Objective In this study, we explore the effect of TIIA on AR.
Qing Chen   +6 more
doaj   +1 more source

Human Lung Mast Cells Impair Corticosteroid Responsiveness in Human Airway Smooth Muscle Cells

open access: yesFrontiers in Allergy, 2021
The mechanisms underlying corticosteroid insensitivity in severe asthma have not been elucidated although some indirect clinical evidence points toward a role of mast cells.
Abdulrahman Alzahrani   +10 more
doaj   +1 more source

Molecular characterisation of Neisseria gonorrhoeae associated with disseminated gonococcal infections in Queensland, Australia: a retrospective surveillance study

open access: yesBMJ Open, 2022
Objectives Gonorrhoea caused by Neisseria gonorrhoeae is the second most notified sexually transmitted infection (STI) in Australia and the case numbers for this STI have been increasing globally. Progressive gonococcal infection may lead to disseminated
David M Whiley   +6 more
doaj   +1 more source

Role of phosphoinositide 3-kinases in mast cell activation [PDF]

open access: yes, 2009
Mast cells are primary effector cells in allergy and chronic inflammation. Class IB (PI3Kγ) and class IA (PI3Kδ) PI3K have been shown to play major roles in mast cell activation: antigen/IgE stimulation triggers autocrine/paracrine activation of mast ...
Collmann, Emilie
core   +1 more source

Home - About - Disclaimer - Privacy